Focus Partners Advisor Solutions LLC Makes New Investment in Leidos Holdings, Inc. $LDOS

Focus Partners Advisor Solutions LLC purchased a new position in shares of Leidos Holdings, Inc. (NYSE:LDOS) during the second quarter, Holdings Channel reports. The institutional investor purchased 3,612 shares of the aerospace company’s stock, valued at approximately $372,000.

Several other institutional investors have also recently made changes to their positions in the company. Bryn Mawr Trust Advisors LLC raised its holdings in shares of Leidos by 4.8% in the fourth quarter. Bryn Mawr Trust Advisors LLC now owns 1,337 shares of the aerospace company’s stock valued at $241,000 after acquiring an additional 61 shares in the last quarter. Cullen Frost Bankers Inc. lifted its stake in Leidos by 19.4% in the fourth quarter. Cullen Frost Bankers Inc. now owns 381 shares of the aerospace company’s stock worth $69,000 after acquiring an additional 62 shares during the period. Keybank National Association OH grew its holdings in Leidos by 3.6% during the 4th quarter. Keybank National Association OH now owns 1,855 shares of the aerospace company’s stock worth $335,000 after acquiring an additional 65 shares in the last quarter. N.E.W. Advisory Services LLC grew its holdings in Leidos by 17.2% during the 4th quarter. N.E.W. Advisory Services LLC now owns 469 shares of the aerospace company’s stock worth $85,000 after acquiring an additional 69 shares in the last quarter. Finally, Glenmede Investment Management LP increased its position in Leidos by 3.2% during the 3rd quarter. Glenmede Investment Management LP now owns 2,240 shares of the aerospace company’s stock valued at $423,000 after purchasing an additional 69 shares during the period. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Leidos Stock Performance

LDOS stock opened at $143.81 on Wednesday. Leidos Holdings, Inc. has a one year low of $98.86 and a one year high of $205.77. The firm has a market cap of $18.05 billion, a price-to-earnings ratio of 13.41, a PEG ratio of 2.09 and a beta of 0.52. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.60 and a current ratio of 1.63. The firm has a 50-day simple moving average of $115.83 and a two-hundred day simple moving average of $141.81.

Leidos (NYSE:LDOS) last issued its quarterly earnings data on Tuesday, August 4th. The aerospace company reported $3.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.35. The firm had revenue of $4.56 billion for the quarter, compared to the consensus estimate of $4.44 billion. Leidos had a net margin of 7.80% and a return on equity of 30.81%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.21 EPS. Leidos has set its FY 2026 guidance at 12.200-12.500 EPS. On average, equities analysts forecast that Leidos Holdings, Inc. will post 12.38 EPS for the current fiscal year.

Leidos announced that its board has approved a share repurchase plan on Friday, July 31st that allows the company to repurchase 20,000,000 shares. This repurchase authorization allows the aerospace company to purchase shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

Leidos Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Tuesday, September 15th. Leidos’s payout ratio is currently 16.04%.

Insider Activity

In other news, Director Noel B. Geer sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $140.66, for a total transaction of $1,406,600.00. Following the completion of the sale, the director owned 34,274 shares in the company, valued at approximately $4,820,980.84. This represents a 22.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.77% of the company’s stock.

Wall Street Analyst Weigh In

LDOS has been the subject of several recent research reports. Jefferies Financial Group restated a “hold” rating and issued a $145.00 price target on shares of Leidos in a report on Sunday, August 9th. Wells Fargo & Company set a $165.00 price objective on shares of Leidos in a research note on Monday. Truist Financial cut their price objective on shares of Leidos from $195.00 to $160.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Royal Bank Of Canada reduced their price objective on shares of Leidos from $180.00 to $170.00 and set an “outperform” rating for the company in a research note on Wednesday, August 5th. Finally, The Goldman Sachs Group lowered their target price on Leidos from $152.00 to $132.00 and set a “neutral” rating for the company in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $162.93.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.